Skip to main content

Veru Inc.

VERU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000863894

No open-market purchases or sales by Veru Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q3 2026, worth $6.92M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 19, 2026
$36.0M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, −4 vs. previous quarter
56
13F valueReported value at the end of Q3 2026
$6.92M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
–
No comparable prior period
Net income, FY2025
-$22.7M
No comparable prior period
Free cash flow, FY2025
-$30.0M
No comparable prior period
Revenue, Q3 FY2026
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
1.50M
Shares sold short
Change
+33.6K
+2.3% vs. previous
Days to cover
13.25
At average daily volume

Superinvestors holding VERU, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding VERU at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Veru Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 17, 2026 (view filing)4:26 PM ETAug 134 daysBarnette K GaryChief Scientific OfficerPPurchase+1.80K$2.69+$4.84K+360.0%2.30K after
Feb 20, 2025 (view filing)Feb 18-192 daysRankowitz Michael LDirectorPPurchase+150.0K$0.5609+$84.1K+150.0%250.0K after2 lots
May 28, 2024 (view filing)May 244 daysFisch HarryChief Corporate OfficerPPurchase+4.00K$1.25+$5.00K+0.5%774.7K after
May 24, 2024 (view filing)May 24Same dayBarnette K GaryChief Scientific OfficerPPurchase+5.00K$1.34+$6.70KNew position5.00K after
May 24, 2024 (view filing)May 22-242 daysSteiner Mitchell ShusterPresident and CEOSSale−70.2K$1.25−$87.4K−1.0%6.94M after3 lots
May 17, 2024 (view filing)May 152 daysFisch HarryChief Corporate OfficerPPurchase+6.71K$1.49+$10.0K+0.9%770.7K after
May 17, 2024 (view filing)May 15-172 daysSteiner Mitchell ShusterPresident and CEOSSale−171.9K$1.44−$247.4K−2.4%7.01M after3 lots
Aug 17, 2022 (view filing)Aug 152 daysEisenberger MarioDirectorSSale−100.0K$20.04−$2.00M−100.0%0 after
Aug 19, 2021 (view filing)Aug 172 daysLu LucyDirectorPPurchase+4.80K$6.78+$32.5K+96.0%9.80K after

Top 10 13F holders, Q3 2026

See all 56 holders

The largest institutional positions in Veru Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding VERU in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Capital Management LLC690,105$1.84M0.00%−8,334−1.2%Reduced
Renaissance Technologies LLC207,450$551.8K0.00%+43,000+26.1%Added
Oppenheimer & Co Inc196,547$522.8K0.01%−14,296−6.8%Reduced
Geode Capital Management, LLC194,231$516.8K0.00%+39,155+25.2%Added
BlackRock, Inc.164,802$438.4K0.00%−2,282−1.4%Reduced
Summit Financial, LLC140,955$374.9K0.00%−910−0.6%Reduced
Gsa Capital Partners LLP129,431$344.0K0.02%−27,905−17.7%Reduced
Schonfeld Strategic Advisors LLC88,798$236.2K0.00%+88,798New
Raymond James Financial Inc81,872$217.8K0.00%−3,097−3.6%Reduced
Vanguard Fiduciary Trust Co81,230$216.1K0.00%00.0%Unchanged

Holders of 5% or more of VERU

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Veru Inc..

Largest holders of VERU from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Alyeska Investment Group, L.P.13G9.90%1.59M sharesNewFeb 17, 20261 filingFeb 17, 2026SEC